1. Home >
  2. M&A >
  3. Merger >
  4. United States >
  5. California >
  6. MabVax Therapeutics Holdings Acquires Telik

M&A Deal Summary

MabVax Therapeutics Holdings Acquires Telik

On May 12, 2014, MabVax Therapeutics Holdings acquired life science company Telik

Acquisition Highlights
  • This is MabVax Therapeutics Holdings’ 1st transaction in the Life Science sector.
  • This is MabVax Therapeutics Holdings’ 1st transaction in the United States.
  • This is MabVax Therapeutics Holdings’ 1st transaction in California.

M&A Deal Summary
Date 2014-05-12
Target Telik
Sector Life Science
Buyer(s) MabVax Therapeutics Holdings
Deal Type Merger

Target

Telik

Palo Alto, California, United States
Telik, Inc. is a biopharmaceutical company dedicated to discovering, developing and commercializing novel small molecule drugs to treat cancer and other serious diseases.

Search 214,356 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

MabVax Therapeutics Holdings

San Diego, California, United States
Category Company
Founded 2006
Sector Life Science
Employees6
DESCRIPTION

MabVax Therapeutics Holdings, Inc. is a clinical stage biotechnology company focused on the development of vaccine and antibody-based therapies to address unmet medical needs in the treatment of cancer.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Merger M&A Deals 1 of 1
State: California M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2014 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal